(Q43011656)

12 November 2017

Inhibition of mitochondrial function by efavirenz increases lipid content in hepatic cells (English)

1 reference

12 November 2017

1 reference

Daniel Ballesteros

3

0 references

Nadezda Apostolova

object named as

Nadezda Apostolova

2

0 references

Milagros Rocha

object named as

Milagros Rocha

6

0 references

Víctor M Víctor

object named as

Victor M Victor

7

0 references

author name string

Ana Blas-García

1

1 reference

12 November 2017

Daniel Monleón

4

1 reference

12 November 2017

Jose M Morales

5

1 reference

12 November 2017

Juan V Esplugues

8

1 reference

12 November 2017

language of work or name

English

0 references

publication date

1 July 2010

1 reference

12 November 2017

1 reference

12 November 2017

52

1 reference

12 November 2017

1

1 reference

12 November 2017

115-125

1 reference

Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team

12 November 2017

1 reference

Combination therapy with efavirenz, nelfinavir, and nucleoside reverse-transcriptase inhibitors in children infected with human immunodeficiency virus type 1. Pediatric AIDS Clinical Trials Group 382 Team

21 January 2018

1 reference

Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel

21 January 2018

1 reference

An extremely different dysmetabolic profile between the two available nonnucleoside reverse transcriptase inhibitors: efavirenz and nevirapine

21 January 2018

1 reference

The role of efavirenz compared with protease inhibitors in the body fat changes associated with highly active antiretroviral therapy

21 January 2018

1 reference

Prediction of neuropsychiatric adverse events associated with long-term efavirenz therapy, using plasma drug level monitoring

21 January 2018

1 reference

Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: role of hepatitis C and B infections

21 January 2018

1 reference

Central role of mitochondria in metabolic regulation of liver pathophysiology

21 January 2018

1 reference

Hepatotoxicity due to mitochondrial dysfunction

21 January 2018

1 reference

A targeted antioxidant reveals the importance of mitochondrial reactive oxygen species in the hypoxic signaling of HIF-1alpha.

21 January 2018

1 reference

Regulation of oxygen distribution in tissues by endothelial nitric oxide

21 January 2018

1 reference

Nile red: a selective fluorescent stain for intracellular lipid droplets

21 January 2018

1 reference

Metabonomics in pharmaceutical R&D.

21 January 2018

1 reference

Cell biology. Great balls of fat.

21 January 2018

1 reference

21 January 2018

1 reference

Inhibition of mitochondrial respiration by endogenous nitric oxide: a critical step in Fas signaling

21 January 2018

1 reference

Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients

21 January 2018

1 reference

Interpatient variability in the pharmacokinetics of the HIV non-nucleoside reverse transcriptase inhibitor efavirenz: the effect of gender, race, and CYP2B6 polymorphism

21 January 2018

1 reference

Increased long-term mitochondrial toxicity in combinations of nucleoside analogue reverse-transcriptase inhibitors

21 January 2018

1 reference

Does nitric oxide modulate mitochondrial energy generation and apoptosis?

21 January 2018

1 reference

Lymphocyte mitochondrial depolarization and apoptosis in HIV-1-infected HAART patients

21 January 2018

1 reference

AZT causes tissue-specific inhibition of mitochondrial bioenergetic function.

21 January 2018

1 reference

AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy

21 January 2018

1 reference

In vitro suppression of the lipogenic pathway by the nonnucleoside reverse transcriptase inhibitor efavirenz in 3T3 and human preadipocytes or adipocytes.

21 January 2018

1 reference

Role of reactive oxygen species-mediated mitochondrial dysregulation in 3-bromopyruvate induced cell death in hepatoma cells : ROS-mediated cell death by 3-BrPA.

21 January 2018

1 reference

Activation of AMP-activated protein kinase in the liver: a new strategy for the management of metabolic hepatic disorders

21 January 2018

1 reference

Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity

21 January 2018

1 reference

Efavirenz--still first-line king?

21 January 2018

1 reference

7 January 2021

Complex I dysfunction and tolerance to nitroglycerin: an approach based on mitochondrial-targeted antioxidants

1 reference

7 January 2021

Effect of 8.5% and 25% caloric restriction on mitochondrial free radical production and oxidative stress in rat liver

1 reference

7 January 2021

Steatohepatitis-inducing drugs cause mitochondrial dysfunction and lipid peroxidation in rat hepatocytes

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.23647

1 reference

12 November 2017

1 reference